546
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Plant-based research among the International Cooperative Biodiversity Groups

&
Pages 783-787 | Received 03 May 2009, Accepted 04 May 2009, Published online: 22 Jul 2009

References

  • Ravintsara (2006): Ravintsara Newsletter Malagasy Plants 4: 10. Available at http://www.mobot.org/MOBOT/Research/madagascar/Vol4Iss1.pdf (accessed July 8, 2009).
  • Averyanov LV, Averyanova AL (2003): Updated Checklist of the Orchids of Vietnam. Hanoi, Vietnam National University Publishing House, pp. 92–96.
  • Beattie AJ, Barthlott W, Elisabetsky E, Farrel R, Kheng CT, Prance I, Rosenthal J, Simpson D, Leakey R, Wolfson M, ten Kate K (2005): New products and industries from biodiversity, in: Hassan R, Scholes R, Ash N, eds, Ecosystems and Human Well-Being, Vol 1, Current State and Trends. Millennium Ecosystem Assessment. Washington DC, Island Press. Available at http://www.maweb.org//en/products.global.condition.aspx (accessed July 8, 2009).
  • Cao S, Guza RC, Wisse JH, Evans R, van der Werff H, Miller JS, Kingston DGI (2005): Ipomoeasssins A-E, five new cytotoxic macrocyclic glycoresins, from the leaves of Ipomoea squamosa from the Suriname rainforest. J Nat Prod 68: 487–492.
  • Cao S, Norris A, Wisse JH, Miller JS, Evans R, Kingston DGI (2007): Ipomoeassins F, a new cytotoxic macrocyclic glycoresin from the leaves of Ipomoea squamosa from the Suriname rainforest. Nat Prod Res 21: 872–876.
  • CBD (Convention on Biological Diversity) (1992): Text of the Convention on Biological Diversity. Available at http://www.cbd.int/convention/convention.shtml (accessed July 8, 2009).
  • Chivian E, Bernstein A (2008): Sustaining Life: How Human Health Depends on Biodiversity. Oxford Press, London, 568 pp.
  • Correa J, Rios C, Castillo A, Romero LI, Ortaga-Barria E, Coley PD, Kursar TA, Heller MV, Gerwick WH, Cubilla-Rios L (2006): Minor alkaloids from Guaterria dumetorum with antileishmanial activiy. Planta Med 72: 270–272.
  • Dey M, Ripoll C, Pouleva R, Dorn R, Aranovich I, Zaurov D, Kurmukov A, Eliseyeva M, Belolipov I, Akimaliev A, Sodombekov I, Akimaliev D, Lila MA, Raskin I (2008): Plant extracts from Central Asia showing anti-inflammatory activities in gene expression assays. Phytother Res 22: 929–934.
  • Fogarty International Center (2009): About Fogarty. Available at http://www.fic.nih.gov/about/index.htm (accessed July 8, 2009)
  • Ma CY, Case RJ, Wang YH, Zhang H-J, Tan GT, Hung NV, Cuong NM, Franzblau SG, Soejarto DD, Fong HHS, Pauli G (2005): Anti-tuberculosis constituents from the stem bark of Micromelum hirsutum. Planta Med 71: 261–267.
  • MEA (2005). Millenium Ecosystem Assessment Reports. Ecosystems and Human Well-Being, Vols. 1, 2, and 3. Washington DC, Island Press. Available at http://www.millenniumassessment.org/en/Global.aspx (accessed July 8, 2009).
  • Montenegro H, Gutierrez M, Romero LI, Ortega-Barria E, Capson TL, Cubilla-Rios L (2003): Aporphine alkaloids from Guatteria spp. with leishmanicidal activity. Planta Med 69: 677–679.
  • Newman DJ, Cragg GM, Snader KM (2003): Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022–1037.
  • Newman DJ, Cragg GM (2007): Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461–477.
  • Nguyen HQ, Tebbitt MC (2005): An unusual new species of Begonia (Begoniaceae) from Vietnam. Gardens’ Bull. Singapore 57: 247–251.
  • Noro JC, Barrows LR, Gideon OG, Ireland CM, Koch M, Matainaho T, Piskaut P, Pond CD, Bugni TS (2008): Tetrahydroxysqualene from Rhus taitensis shows antimycobacterial activity against Mycobacterium tuberculosis. J Nat Prod 71: 1623–1624.
  • Rosenthal JP (1999): Drug discovery, economic development and conservation: The International Cooperative Biodiversity Groups. Pharm Biol 37: 1–144.
  • Rosenthal JP, Beck DA, Bhat A, Biswas J, Brady L, Bridbord K, Collins S, Cragg G, Edwards J, Fairfield A, Gottlieb M, Gschwind LA, Hallock Y, Hawks R, Hegyeli R, Johnson G, Keusch GT, Lyons EE, Miller R, Rodman J, Roskoski J, Siegel-Causey D (1999): Combining high risk science with ambitious social and economic goals. Pharm Biol 37: 6–21.
  • Rosenthal JP, Katz FN (2004): Natural products research partnerships with multiple objectives in global biodiversity hotspots: Nine years of the International Cooperative Biodiversity Groups Program, in: Bull AT ed., Microbial Diversity and Bioprospecting. Washington, DC, ASM Press, pp. 458–466.
  • Schweitzer J, Handley FG, Edwards J, Harris WF, Grever MR, Schepartz SA, Cragg G, Snader K, Bhat A (1991): Summary of the workshop on drug development, biological diversity, and economic growth. J Natl Cancer Inst 83: 1294–1298.
  • Soejarto DD, Zhang HJ, Fong HHS, Tan GT, Ma CY, Gyllenhaal C, Riley MC, Kadushin MR, Franzblau SG, Bich TQ, Cuong NM, Hiep NT, Loc PK, Xuan LT, Hai NV, Hung NV, Chien NQ, Binh LT, Vu BM, Ly HM, Southavong B, Sydara K, Bouamanivong S, Pezzuto JM, Rose WC, Dietzman GR, Miller BE, Thuy TV (2006): Studies on biodiversity of Vietnam and Laos 1998-2005: Examining the impact. J Nat Prod 69, 473–481.
  • UNESCO (2009): Coiba National Park and its Special Zone of Marine Protection. Available at http://whc.unesco.org/en/list/1138 (accessed July 8, 2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.